Pharma’s AI Boom Has Bet on the Wrong Bottleneck - promarket.org

The pharmaceutical industry has invested heavily in AI to solve drug discovery, but may have focused on the wrong challenges. This matters because it affects how quickly and affordably new medicines reach patients.